| Stereochemistry | ABSOLUTE |
| Molecular Formula | C16H15FN4O |
| Molecular Weight | 298.3149 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@]12CCCN1CC3=NNC(=O)C4=C5C(NC2=C35)=CC(F)=C4
InChI
InChIKey=DENYZIUJOTUUNY-MRXNPFEDSA-N
InChI=1S/C16H15FN4O/c1-16-3-2-4-21(16)7-11-13-12-9(15(22)20-19-11)5-8(17)6-10(12)18-14(13)16/h5-6,18H,2-4,7H2,1H3,(H,20,22)/t16-/m1/s1
| Molecular Formula | C16H15FN4O |
| Molecular Weight | 298.3149 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
| 0.83 nM [IC50] | |||
| 0.11 nM [IC50] |
